Compromised cytotoxicity in MS NK cells may result from upregulated T cell expression of HLA‐E, the ligand for the inhibitory receptor NKG2A,29 or downregulated DNAM‐1/CD155‐mediated NK cell priming.83 The gene discussed is HLA-E; the disease is myeloid sarcoma.